Uniqure NV

General ticker "QURE" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $522.4M

Uniqure NV follows the US Stock Market performance with the rate: 27.9%.

Estimated limits based on current volatility of 9.0%: low 16.15$, high 17.93$

Factors to consider:

  • Current price 102.9% above estimated high
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.57$, 8.55$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.84$, 6.79$]

Financial Metrics affecting the QURE estimates:

  • Negative: Non-GAAP EPS, $ of -6.48 <= 0.10
  • Negative: Operating profit margin, % of -94.70 <= 1.03
  • Negative: Operating cash flow per share per price, % of -30.15 <= 2.35
  • Negative: negative Net income
  • Negative: Inventory ratio change, % of 46.94 > 1.08

Similar symbols

Short-term QURE quotes

Long-term QURE plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $524.00MM $106.48MM $15.84MM
Operating Expenses $213.38MM $249.64MM $298.71MM
Operating Income $310.62MM $-143.16MM $-282.87MM
Non-Operating Income $22.19MM $14.90MM $-23.69MM
Interest Expense $7.47MM $11.70MM $41.56MM
R&D Expense $143.55MM $197.59MM $214.86MM
Income(Loss) $332.81MM $-128.26MM $-306.56MM
Taxes $3.22MM $-1.47MM $1.92MM
Profit(Loss) $329.59MM $-126.79MM $-308.48MM
Stockholders Equity $595.78MM $476.01MM $207.67MM
Inventory $10.54MM $6.92MM $12.02MM
Assets $809.18MM $704.96MM $831.69MM
Operating Cash Flow $287.96MM $-145.06MM $-145.93MM
Capital expenditure $17.44MM $17.69MM $7.15MM
Investing Cash Flow $-67.39MM $-182.73MM $-205.69MM
Financing Cash Flow $94.86MM $1.45MM $362.72MM
Earnings Per Share* $7.17 $-2.71 $-6.47

* EPS are Split Adjusted, recent splits may be reflected with a delay.